NEET
Biotechnology And Its Applications PYQNEET 2022 Phase 1
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
Solution
Correct option: D
Answer: D. Genetically engineered lymphocytes are not immortal cells.
Identify the treatment setup
In ADA deficiency gene therapy, lymphocytes are taken from the patient and genetically engineered outside the body.
Recall the limitation
These corrected lymphocytes do not keep dividing forever; they have a limited lifespan.
Connect to periodic infusion
Since the engineered lymphocytes die after some time, fresh corrected lymphocytes must be infused periodically.
Eliminate the permanent-cure case
If the ADA-producing gene were introduced at an early embryonic stage, it could provide a permanent cure, so that is not the reason here.
